Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: Biology, clinical results and future development

Brian I. Rini*, Jeffrey A. Sosman, Robert J. Motzer

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

47 Scopus citations
Original languageEnglish (US)
Pages (from-to)286-290
Number of pages5
JournalBJU International
Volume96
Issue number3
DOIs
StatePublished - Aug 2005

Keywords

  • BAY 43-9006
  • Bevacizumab
  • RCC
  • SU11248
  • VEGF
  • VHL

ASJC Scopus subject areas

  • Urology

Cite this